Stephen Lade (S Lade)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Peritoneal Dialysis

Chronic Lymphocytic Leukemia

Top Venues

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Sasanka Mithila Handunnetti, Mary Ann Anderson, Kate I Burbury, Phillip A Thompson, Glenda Burke, Mathias Bressel, Juliana L Di Iulio, Rodney John Hicks, David A Westerman, Stephen Lade, Christiane Pott, Rishu Agarwal, Rachel M Koldej, David Ritchie, Martin Dreyling, Mark A Dawson, Sarah-Jane Dawson, John Francis Seymour, Andrew W Roberts, Constantine S Tam
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions. Blood (2024)
Sasanka Mithila Handunnetti, Mary Ann Anderson, Kate I Burbury, Phillip A Thompson, Glenda Burke, Mathias Bressel, Juliana Di Iulio, Rodney John Hicks, David Westerman, Stephen Lade, Christiane Pott, Rishu Agarwal, Rachel M Koldej, David S Ritchie, Martin Dreyling, Mark A Dawson, Sarah-Jane Dawson, John Francis Seymour, Andrew W Roberts, Constantine S Tam
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions. Blood 144 (8) (2024)
S Robinson, S Wu, Stephen Lade, C S Tam, E Wong, Amit Khot, P Blombery
CD274 structural variants for guiding treatment with PD-1 blockade in a patient with relapsed/refractory chronic active EBV transformed to NK lymphoma. Leukemia & lymphoma (2024)
Adrian G Minson, Nada Hamad, Chan Yoon Y Cheah, Constantine S Tam, Piers Blombery, David A Westerman, David S Ritchie, Huw Morgan, Nicholas Holzwart, Stephen Lade, Mary Ann Anderson, Amit Khot, John Francis Seymour, Molly Robertson, Imogen Caldwell, Georgina L Ryland, Javad Saghebi, Zahra Sabahi, Jing Xie, Rachel M Koldej, Michael J Dickinson
CAR T-cells and Time-Limited Ibrutinib as Treatment for Relapsed/Refractory Mantle Cell Lymphoma: Phase II TARMAC Study. Blood (2023)